Snapshot from Nov 22, 2026 at 07:00 UTC. For live data and tracking: View Live
Company

Surrozen

Tracked across 1 events · 7 articles · First seen Sep 08, 2026 · Last active Sep 08, 2026

Sentiment
10
Attention
2
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
2 10
Regulatory
Surrozen, Inc. announced the submission of an Investigational New Drug (IND) application to the U.S. United States — Food and Drug Administration for SZN-8141, a bifunctional Wnt agonist and VEGF antagonist antibody, for the treatment…
Impact: Surrozen is the developer of SZN-8141 and the submitter of the IND. This milestone advances its lead candidate toward clinical trials, potentially enhancing its pipeline value, though the stock saw a slight decline.
Sep 08, 2026 · 7 articles
ERGEN INTELLIGENCE
Track Surrozen live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.